Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy.
about
Ubiquitin-proteasome system as a modulator of cell fatePatterns of ubiquitylation and SUMOylation associated with exposure to anoxia in embryos of the annual killifish Austrofundulus limnaeusProteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI.Identification of network-based biomarkers of cardioembolic stroke using a systems biology approach with time series data.Prepartal Energy Intake Alters Blood Polymorphonuclear Leukocyte Transcriptome During the Peripartal Period in Holstein CowsThe ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.VACM-1/cul5 expression in vascular tissue in vivo is induced by water deprivation and its expression in vitro regulates aquaporin-1 concentrations.A novel role of proteasomal β1 subunit in tumorigenesis.Physiological levels of ATP negatively regulate proteasome function.Effects of N-stearoyl-L-tyrosine on the hippocampal ubiquitin-proteasome system in rats with chronic cerebral hypoperfusion.Comprehensive gene expression profiling reveals synergistic functional networks in cerebral vessels after hypertension or hypercholesterolemia.Quantitative analysis of a ubiquitin-dependent substrate using capillary electrophoresis with dual laser-induced fluorescence.Implications of protein post-translational modifications in IBD.The ubiquitin-proteasome system in HIV replication: potential targets for antiretroviral therapy.The neurovascular unit and combination treatment strategies for strokeInhibition of immunoproteasome reduces infarction volume and attenuates inflammatory reaction in a rat model of ischemic stroke.Huwe1 interacts with Gadd45b under oxygen-glucose deprivation and reperfusion injury in primary Rat cortical neuronal cells.Glutamine attenuates inflammation and NF-kappaB activation via Cullin-1 deneddylation.Morphine induces ubiquitin-proteasome activity and glutamate transporter degradation.Neuronal necrosis and spreading death in a Drosophila genetic modelEffect of a low dose of proteasome inhibitor on cell death and gene expression in neonatal rat cardiomyocyte cultures exposed to anoxia-reoxygenationThe role of the ubiquitin proteasome system in ischemia and ischemic tolerance.Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein responseCerebral hypoperfusion increases estrogen receptor abundance in the ovine fetal brain and pituitary.Glucocorticoid regulates parkin expression in mouse frontal cortex: implications in schizophrenia.The R18 Polyarginine Peptide Is More Effective Than the TAT-NR2B9c (NA-1) Peptide When Administered 60 Minutes after Permanent Middle Cerebral Artery Occlusion in the Rat.Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation.Inhibition of the ubiquitin-proteasome activity prevents glutamate transporter degradation and morphine tolerance.Nrdp1 Increases Ischemia Induced Primary Rat Cerebral Cortical Neurons and Pheochromocytoma Cells Apoptosis Via Downregulation of HIF-1α Protein.Combined 3D-QSAR, molecular docking and molecular dynamics study on derivatives of peptide epoxyketone and tyropeptin-boronic acid as inhibitors against the β5 subunit of human 20S proteasome.Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2.Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis.The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury.Significance of Mitochondrial Protein Post-translational Modifications in Pathophysiology of Brain Injury.Cardiac Arrest Alters Regional Ubiquitin Levels in Association with the Blood-Brain Barrier Breakdown and Neuronal Damages in the Porcine Brain.Expression of nitric oxide synthase isoforms in the ovine fetal brain: alteration by hormonal and hemodynamic stimuli.Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat.Proteasome Stress Triggers Death of SH-SY5Y and T98G Cells via Different Cellular Mechanisms.The ubiquitin-proteasome system: a novel target for anticancer and anti-inflammatory drug research.Perinatal Hypoxic-Ischemic Encephalopathy and Neuroprotective Peptide Therapies: A Case for Cationic Arginine-Rich Peptides (CARPs)
P2860
Q24656277-9D865CB8-7E99-4F07-AC64-3D466C0C0FB0Q30356816-910D97B2-503F-44E1-B5EE-4BA926F5CDF3Q30479870-0E0B1B53-3089-46E7-A03C-1F166DB6F8C0Q31032654-6FFFF0F8-1968-48EA-A1B2-DF498B9BD79DQ33631201-7BCA169F-073B-49D6-8BC9-36FCF5EF48F8Q33892755-0747DE74-23A6-4ED9-9D2C-C7EE98226CB7Q34031947-0D97FA7A-10FC-410A-B246-DBD1F70F89A3Q34347861-80BE5608-48A0-4BFA-B4AE-8F37BF4E5164Q34376187-297315E6-CD0D-4687-A1ED-5C130532B40CQ34657217-B2FC0416-129B-4F44-AF7D-FDD6C9B82AA5Q34848063-B905CE76-2236-4AED-8646-DA1F94474EADQ35214583-3637DE7D-E041-4462-BF4B-A1BAE5480F9FQ36041758-11358A3A-2120-4EB1-9CE3-268D7DD1C47BQ36066214-5DF2ECF1-36F7-4774-A264-4562D588D25FQ36124038-8D97B778-FC28-48B5-8C5B-DD1FBBF5DFF5Q36347192-B99304D1-E9EB-4A44-BBEF-219440EF4C94Q36402090-E194426C-E6B4-4F17-82C8-0087145D1038Q36763544-3D35B1E7-16AB-40C9-8C9F-EBAF416D1EF0Q36798747-83B6A75A-D31D-4458-BC3E-FC004E0D2B55Q37062009-8C02F80D-3B7E-4DB3-A64F-95A54E0DA2BAQ37293706-12097333-0434-483A-B552-6BADD00A9CE7Q37381217-199B1993-9152-45C6-91D4-671CCDDDECF3Q37448609-29E45D04-CA58-4CE8-B4B5-C5B6779B6D17Q37475471-0D135DFF-E6A5-466D-A305-5526A098F2F5Q37661354-69AFCD9E-53E9-4637-9EF4-7F36A6850596Q41821231-B1F88CE3-6C6C-4D2D-A423-3E026C11DB40Q41872746-96B5D580-C631-4BC3-ACCF-6A2AEC9DA089Q41961680-ABD34334-3678-4D28-A046-09EC2F02ED7DQ42363212-59E3BF40-686B-418B-84C5-17D20041B6C2Q42751397-CF688350-E136-468C-9498-EE5950776A5DQ43292310-4A6FA6C0-F91A-4BEE-A0F8-253015E92071Q45969381-C0696EA7-BE53-4DA4-B819-7D71FCFF03B9Q46003331-750E58A6-0FA6-4CED-A674-9758D3AF0F2EQ47761796-1DB29E99-EC71-49D6-919F-61A5C3D7B53BQ48111333-052F3A4A-253B-449F-8148-10368DFC0FA1Q48510141-34364323-FBA9-48EB-BB13-5EC2FA1E4143Q50094040-941868FA-F205-4141-8392-AC45BC45895EQ50880972-64453269-4998-42FA-B5CB-4A81B1B40786Q53495126-5641EEF5-FF05-403D-BE30-EE0C516C525BQ57929840-1A42674F-075B-4062-AE40-06BB28324E95
P2860
Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy.
@ast
Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy.
@en
type
label
Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy.
@ast
Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy.
@en
prefLabel
Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy.
@ast
Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy.
@en
P1433
P1476
Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy
@en
P2093
Cezary Wojcik
P304
P356
10.1161/01.STR.0000126891.93919.4E
P407
P577
2004-04-29T00:00:00Z